Stem Cell gets patents in U.S. and Japan

Stem Cell Therapeutics (TSX-V:SSS) has received notification of the issuance of two new patents in the U.S. and Japan. The U.S. patent relates to the use of the pregnancy hormone, human chorionic gonadotropin (hCG), to treat patients presenting with damaged or diseased heart cells. The Japanese patent relates to the use of granulocyte colony stimulating [...]

Dundee biotech outlook sees ‘ample room for upside’

While we were at the J.P. Morgan Healthcare Conference in San Francisco last week, Dundee Securities issued its latest biotech sector update. On the bright side, analyst David Martin writes that there are signs Biovail, Angiotech and QLT stocks are bouncing back – supported by new strategies and new products in development for each company. [...]